Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App





Tianlong Demonstrates Latest Biochemistry, Immunology, POCT and Molecular Diagnostic Products

By LabMedica International staff writers
Posted on 12 Nov 2024

Tianlong Science and Technology (Shaanxi, China) is participating in the MEDICA 2024 exhibition where the company is showcasing its cutting-edge diagnostic solutions and latest products in biochemistry, immunology, POCT, and molecular diagnostics. More...

Among Tianlong’s innovations featuring at this year’s MEDICA is the Panall 8000 All-in-one Molecular Diagnosis system (Open system) that enables laboratories to program user-defined PCR analysis protocols. Laboratories can use user-defined protocols in addition to those developed by Tianlong. The simple and efficient design of the Panall 8000 allows labs to test a wide range of sample types and meet emerging diagnostic requirements through customized reagents. Tianlong intends to bring more new tests to the Panall 8000 for detection of a broad range of disease categories.

Also featuring at MEDICA 2024 is the Gentier X3 Series Real-Time PCR System that features three independent thermal blocks, supporting users to run a maximum 3×32 well samples in three different protocols simultaneously. This can help labs save a lot of time and budget. With the powerful and efficient temperature control system, user-friendly operational designs, Tianlong Gentier X3 Series can provide maximal reliability and efficiency for all real-time PCR needs. Tianlong is also highlighting the Biolum Portable ATP Hygiene Monitoring System Pro which features an innovative design, making it a smartphone in the user’s hand. Featuring state-of-the-art technology, the new device can provide rapid and accurate data to support hygiene monitoring programs. Cloud-based data management enables users to monitor, track, and trend testing results across multiple facilities, making risk management easier than ever.

Additionally, Tianlong is presenting the V150 automatic chemiluminescence immunoassay analyzer designed for small and medium-sized laboratories, while also offering the capability for emergency testing in large hospitals and third-party laboratories. Alongside, Tianlong is highlighting the ZY-260 automatic clinical chemistry analyzer that uses concave grating photometry post-spectroscopic technology and has a constant speed of 200 tests/hour. The ZY-260 also features an AAA-supported system with improved traceability for ensuring the accuracy of results and has a high-capacity sample tray and reagent tray, allowing 72 clinical chemistry items to be run simultaneously.

Related Links:
Tianlong Science and Technology


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Portable POCT Blood Gas Analyzer
BD100
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.